Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-01-15

Clinical Trial Update: Long Term Significance (Survival) of LCI in Patients With Cystic Fibrosis

View source ↗

Summary

This clinical trial update indicates a study evaluating the long-term significance of Lung Clearance Index (LCI) in cystic fibrosis patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital St Luc, Brussels | Conditions: Cystic Fibrosis (CF) | Status: WITHDRAWN